Reduced Lung Metastasis in Mice Lacking Endothelial TGF-β Receptor
Author Information
Author(s): Hanada Kako, Saito Yuki, Takagi Takahiro, Go Mitsuki, Nakano Yota, Inagawa Toshihiko, Hirai Hideyo, Fruttiger Marcus, Itoh Susumu, Itoh Fumiko
Primary Institution: Tokyo University of Pharmacy and Life Sciences
Hypothesis
How does the deletion of the TGF-β type II receptor in endothelial cells affect tumor angiogenesis and metastasis?
Conclusion
The study found that endothelial-specific deletion of TGF-β signaling reduces lung metastasis despite increased circulating tumor cells.
Supporting Evidence
- Endothelial-specific TGF-β receptor knockout leads to fragile tumor vasculature.
- Loss of endothelial TGF-β signaling reduces lung metastasis in tumor-bearing mice.
- TβRII deletion in tumor endothelial cells reduces CD44 expression and increases circulating tumor cells.
- CD44 downregulation inhibits cancer cell adhesion to endothelial cells.
Takeaway
When certain cells in mice that help blood vessels grow are turned off, the mice have fewer cancer cells spreading to their lungs, even though more cancer cells are found in their blood.
Methodology
The study used genetically modified mice with endothelial-specific deletion of the TGF-β type II receptor and assessed tumor growth, angiogenesis, and metastasis through various experimental models.
Limitations
The use of transplanted tumor models may not fully replicate the complexity of naturally occurring cancers.
Participant Demographics
Mice used were TβRIIfl/fl and Pdgfb-iCreER on a C57BL/6J background.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website